New update strongly recommends against use of sotrovimab and casirivimab-imdevimab for patients with COVID-19
Measles Returns to Australia in 2022
Australia's NSW Health recently confirmed the first local case of measles since February 2020. This person developed symptoms after returning to Sydney and is now isolated in a hospital.
This adult acquired the infection while traveling in Asia in August 2022.
As of September 13, 2022, NSW Health says the person spent time in the following Sydney locations while infectious with the measles virus:
Monkeypox Vaccination Eligibility Expanded in New York
The New York State Department of Health (NYSDOH) announced yesterday plans to distribute 3,840 vials of the Monkeypox vaccine known as Jynneos® (MVA-BN, IMVANEX®). It will also be made available to all individuals at risk of becoming infected as vaccine eligibility is expanded.
Before the expansion on September 14, 2022, Jynneos's vaccine eligibility was limited to those likely exposed to the monkeypox virus (MPXV).
Pediatric Brain Abscess, Empyema Hospitalizations Peaked in March 2022
March 2022 peak in cases linked to Streptococcus species consistent with historical seasonal fluctuations seen since 2016
WHO Says Pandemic’s End May Be Near
About 11,000 people around the world died from COVID-19 during the week of Sept. 5 to 11, a drop of 22 percent from the previous week
USA Loses Polio-Free Status
The U.S. CDC announced yesterday that polioviruses found in New York wastewater samples and a local case of paralytic polio in an unvaccinated person in Rockland County mean that poliovirus continues to be transmitted in surrounding areas.
The viral sequences from the Rockland County patient and three wastewater specimens had enough genetic changes to meet the vaccine-derived poliovirus (VDPV) definition.
Gestational Weight Gain in the U.S. Higher During the Pandemic
Higher gestational weight gain and higher risk for excessive gestational weight gain seen for singleton pregnancies
COVID-19 Hospitalization Rates Higher in Unvaccinated During Omicron
Hospitalization rates 2.5 times higher for vaccinated patients without booster versus those with booster
Some Ultraprocessed Foods May Lead to Broader Consumption for Teens
Study looks at adolescent eating behavior and its implications for modifiable hypertension risk factors
$18 Billion Needed to Defeat HIV, Malaria, and Tuberculosis
The Global Fund’s 2022 Results Report released today indicates a significant rebound for programs working to defeat HIV, tuberculosis (TB), and malaria.
In 2020, the COVID-19 pandemic had a devastating impact on the fight against these three diseases.
When the pandemic hit countries where the Global Fund works, the partnership rapidly mounted a response to deliver additional resources.
Since March 2020, the Global Fund has invested more than US $4.4 billion to fight the pandemic and mitigate its impact on HIV, TB, and malaria.